| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: FA Cellcycle: M |
Permissive
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| SOX2 |
differentiated embryonic stem cells |
Strain: C57BL/6N; |
Permissive
Robust
|
Mus musculus |
GSE93524
...
|
MA0142.1
...
|
| SOX2 |
squamous cell carcinoma |
Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin; |
Permissive
|
Mus musculus |
GSE104142
...
|
MA0142.1
...
|
| SOX2 |
squamous cell carcinoma |
Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin; |
Permissive
|
Mus musculus |
GSE104142
...
|
MA0142.1
...
|
| SOX2 |
E14TG2A (embryonic stem cells) |
Treatment: no Dox; Cell type: 44iN; Characteristic: lif +; |
Permissive
|
Mus musculus |
GSE118898
...
|
MA0142.1
...
|
| SOX2 |
E14TG2A (embryonic stem cells) |
Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +; |
Permissive
Robust
|
Mus musculus |
GSE118898
...
|
MA0142.1
...
|
| SOX2 |
NIH 3T3 (embryonic fibroblasts) |
Genotype: Overexpression of SOX2; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding; |
Permissive
Robust
|
Mus musculus |
GSE119782
...
|
MA0142.1
...
|
| SOX2 |
hippocamus-derived neural progenitor cells |
Strain: mixed C57BL/6 x DBA; Source: hippocamus; |
Permissive
|
Mus musculus |
GSE90559
...
|
MA0142.1
...
|
Showing 10 records in page 627
from 772 pages